MAP3K7 antibody (N-Term)
Quick Overview for MAP3K7 antibody (N-Term) (ABIN2307049)
Target
See all MAP3K7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 130-160, N-Term
-
Cross-Reactivity
- Human, Mouse (Murine)
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu Mo
-
Characteristics
- Map3k7, NT (Map3k7, Tak1, Mitogen-activated protein kinase kinase kinase 7, Transforming growth factor-beta-activated kinase 1)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogen
- Mouse Map3k7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 130-160 amino acids from the N-terminal region of Mouse Map3k7.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- MAP3K7 (Mitogen-Activated Protein Kinase Kinase Kinase 7 (MAP3K7))
-
Alternative Name
- Map3k7
-
NCBI Accession
- NP_766276
-
UniProt
- O43318, Q62073
-
Pathways
- NF-kappaB Signaling, TCR Signaling, TLR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Toll-Like Receptors Cascades, BCR Signaling, Ubiquitin Proteasome Pathway
Target
-